In the present study, we aimed to elucidate the mechanism responsible for constitutive NF-jB DNA-binding activity in AML cells. Intervening in aberrant signaling pathway provides a rational approach for in vivo targeting of AML cells. Constitutive NF-jB DNA-binding activity was observed in 16 of 22 (73%) investigated AML cases and was, in general, associated with resistance to spontaneous apoptosis. Indeed, inhibition of NFjB activity by the NF-jB inhibitor SN-50 peptide resulted in enhanced chemotherapy-induced apoptosis. In the majority of cases, constitutive NF-jB activity was mediated by a Ras/PI3 kinase (PI3-K)/protein kinase B (PKB)-mediated pathway. The PI3-K inhibitor Ly294002 and the Ras inhibitor L-744832 both inhibited PKB phosphorylation and NF-jB DNA-binding activity. The constitutive activation of Ras GTP-ase was caused by mutations in the gene encoding for N-Ras in 29% of the cases. The constitutive NF-jB activity could so far not be ascribed to the autocrine production of growth factors or to mutations in the Flt3 receptor, since anti-GM-CSF, -IL-1, -IL6, -TNFa or the tyrosine kinase inhibitor AG1296 did not affect the NF-jB DNAbinding activity. The present study demonstrates that Ras activation is an important pathway for triggering the NF-jB pathway in AML cells.
Introduction
The transcription factor nuclear factor kappa B (NF-kB) has been studied intensively for its role in controlling the expression of genes involved in immune and inflammatory function. [1] [2] [3] Recently, NF-kB has also been implicated to play an important role in cell growth and oncogenesis. 4 In hematopoietic malignancies, this is demonstrated by the finding that NF-kB can be constitutively expressed in myeloid leukemic progenitor cells. 5 NF-kB is a dimeric transcription factor that consists of proteins that are members of the rel family, which comprises five major proteins: p50, p65 (RelA), c-rel, p52 and RelB. 6, 7 The most abundant NF-kB dimer is the p50/p65 heterodimer.
There are multiple signaling pathways that can potentially activate NF-kB. First, the IKK/IkB/NF-kB signaling pathway can be activated through stimulation of a variety of cell-surface receptors. 1, 8 Although different receptors often use distinct combinations of intracellular proteins to initiate NF-kB activation, the signals converge into a common pathway that leads to the activation of the IkB kinase (IKK) complex. [9] [10] [11] In acute myeloid leukemia (AML), aberrant regulation of IKK signaling has been shown to lead to increased NF-kB activity. 12 In addition to the classical NIK/IKK/IkB pathway, induced by IL-1 or TNFa, it has been described that downstream effectors of the small Ras-GTP-ase can also interfere with the NF-kB pathway. [13] [14] [15] Activating point mutations of the Ras genes have been demonstrated in 20-30% of AML cases which are mostly mutations in the N-Ras gene, but, occasionally, mutations in KRas have been described. 16, 17 Ras activation of the Raf serine/ threonine kinases and the activation of the ERK mitogenactivated protein kinases (MAPKs) remains a key signaling pathway, which is important for many aspects of Ras effector functioning. 18 An additional signal-transduction effector of Ras is the PI3 kinase (PI3-K)/PKB signaling pathway.
19 PI3-K can also activate the Rac GTP-ase, and this Rho family protein is an important mediator of oncogenic Ras transformation. 20 PKB, and also Rac, facilitates Ras activation of NF-kB in some cellular settings, and serves an antiapoptotic role in Ras function. 20, 21 This is in line with observations which describe that in the AMLderived HL60 cell line the PI3-K/PKB pathway plays an important role in chemoresistance, which is distinct from interactions of the proapoptotic protein Bad with Bcl-2 family members. Thus, the PI3-K/PKB pathway is suggested to have different targets. 22 Previously, it has been reported that NF-kB is constitutively activated in leukemic progenitor cells. More importantly, the activation of NF-kB is a major distinguishing characteristic between normal and leukemic stem cells, and provides leukemic cells a growth advantage over the normal hematopoietic stem cell. Therefore, it is important to clearly identify the role and especially the regulation of NF-kB in AML. The identification of these signaling cascades might lead to a more rational approach to interfere with the aberrant proliferation and cell-survival characteristics of leukemic cells. The results of the present study demonstrate that constitutive PI3K-dependent activation of NF-kB DNA-binding activity in AML is triggered by Ras activation in the majority of cases. Activating mutations in the Ras gene contribute only in the minority of the cases.
Materials and methods

Patient population and isolation of AML cells
Peripheral blood cells or bone marrow cells from 22 adult, untreated, patients with AML were studied after informed consent. The AML cases were defined according to the classification of the French-American-British (FAB) committee as M0-M6. 23 AML blasts were isolated by density-gradient centrifugation. The cells were cryopreserved in aliquots of 20-30 Â 10 6 cells in RPMI 1640 (Flow, Rockville, MD, USA) supplemented with 10% dimethylsulfoxide (DMSO; Sigma, St Louis, MO, USA) and 10% fetal bovine serum (FBS; Hyclone, Logan, USA), employing a method of controlled freezing and storage in liquid nitrogen. After thawing, T lymphocytes were depleted by 2-aminoethylisothioronium bromide (AET)-treated sheep red blood cell (SRBC) rosetting. The cell population consisted of more than 98% AML blasts, as determined by MayGrü nwald-Giemsa staining. Fluorescence-activated cell sorting (FACS) analysis demonstrated o1% CD3 (Becton Dickson, Sunnyvale, CA, USA)-positive cells. AML blasts were cultured at 371C at a density of 1 Â 10 6 ml in RPMI 1640 media supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin (ICN, Costa Mesa, CA, USA), 6 ng/ml of colistine and 10% FBS.
Cell culture
The human erythroleukemia cell line TF-1 was cultured in RPMI 1640 supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin (ICN, Costa Mesa, CA, USA), 6 ng/ml of colistine, 5% FBS and 10 ng/ml IL-3 (Genetics Institute, Cambridge, MA, USA). The human monocytic cell line THP-1 was cultured in RPMI 1640 supplemented with 100 U/ml penicillin, 100 mg/ml streptomycin (ICN, Costa Mesa, CA, USA), 6 ng/ml of colistine and 10% FBS.
Combined annexin V/propidium iodide (PI) staining procedure
Viability was assessed by using an annexin V staining kit (IQ Products, Groningen, The Netherlands), according to the manufacturer's recommendations. Briefly, after 24 h of culture in RPMI 1640 medium supplemented with 10% FBS with or without addition of VP-16 (50 mg/ml) (TEVA Pharma) or the specific NF-kB inhibitor SN-50 (100 mg/ml) (Biomol, Plymouth Meeting, PA, USA), cells were harvested, resuspended in 100 ml calcium buffer containing 5 ml of annexin V and incubated for 20 min at 41C in the dark. Cells were washed with 5 ml calcium buffer and subsequently incubated in 300 ml calcium buffer containing 2.5 ml of PI for 10 min in the dark. Subsequently, binding of fluorescein-conjugated annexin V and PI was measured by FACS (Becton Dickinson, Sunnyvale, CA, USA). The specificity of the SN-50 effect was tested by stimulating monocytes with the phorbol ester PMA (50 nM, Sigma, St Louis, MO, USA) during 6 h that were preincubated with or without SN-50. Subsequently, the NF-kB activity was studied by electrophoretic mobility shift assay (EMSA) and p21 (Transduction Laboratories, Lexington, KY, USA) by Western blotting.
Western blotting
The amount of ERK, PKB, p21, actin and the degree of phosphorylated ERK, PKB and STAT5 were determined by Western blotting. AML blasts were cultured for 24 h in RPMI 1640 supplemented with 10% FBS, with or without 50 mM L-744832 (Biomol, Plymouth Meeting, PA, USA), 5 mM Ly294002 (Alexis Biochemicals, Switzerland), 20 mM AG1296 (Calbiochem, La Jolla, CA, USA) or 10 mM PD98059 (Calbiochem, La Jolla, CA, USA) at a density of 1 Â 10 6 cells/ml. TF-1 cells were cultured overnight in RPMI 1640 supplemented with 1% FBS, and subsequently stimulated for 5 min with IL-1b (10 ng/ml) or conditioned AML medium (prepared by incubating AML cells at a density of 3 Â 10 6 cells/ml for 3 days). Cells (3 Â 10 6 ) were harvested and total cell extracts were prepared by resuspending the cells in 100 ml 1 Â sample buffer (containing 2% SDS, 10% glycerol, 2% b-mercaptoethanol, 60 mM Tris-HCl pH 6.8 and bromophenol blue). Cell extracts were directly boiled for 5 min and proteins were fractionated by SDS-PAGE. The proteins were electrophoretically transferred to PVDF membrane (Millipore, Bedford, MA, USA) and probed with antibodies against phospho Thr308-PKB, phospho Ser473-PKB, phospho Ser32-IkB-a, phospho Thr202/Tyr204-ERK (E10) (which recognizes both residues on both ERK1 and 2) (New England BioLabs, Beverly, MA, USA) or phospho Tyr694/Tyr699-STAT5 (Upstate, Charlottesville, VA, USA) (which recognizes the phosphorylated tyrosine 694 residue of STAT5A and the phosphorylated tyrosine 699 residue of STAT5B), PKB (New England Biolabs, Beverly, MA, USA), IkB-a (C-15) or ERK (K23) (Santa Cruz, CA, USA), STAT5A, STAT5B (Upstate, Charlottesville, VA, USA) or monoclonal antibody against Actin (C4) (ICN Biomedicals, Inc., Aurora, OH, USA). Immunocomplexes were detected using enhanced chemiluminescence (ECL, Amersham). Relative protein levels were quantified using the gelscan program Diversity One (Pharmacia, Uppsala, Sweden).
Electrophoretic mobility shift assay AML blasts were cultured for 24 h in RPMI 1640 supplemented with 10% FBS, with or without addition of Ly294002 (5 mM), L-744832 (50 mM), PD98059 (10 mM), SB203580 (1 mM), AG1296 (20 mM), anti-GM-CSF antibody (1 mg/ml) (R&D Systems, UK), anti-IL-6 (1:500) (gift from Dr L Aarden, CLB, Amsterdam), anti-IL-1b (0.1 mg/ml) and anti-TNFa (1:100). The diluted polyclonal antisera were maximally effective at the used concentrations, as studied with in vitro dose-response curves. TF-1 cells were cultured overnight in RPMI 1640 supplemented with 1% FBS, and subsequently stimulated for 15 min with conditioned AML medium (prepared by incubating AML cells at a density of 3 Â 10 6 cells/ml for 3 days) or IL-1b (10 ng/ml). THP-1 cells were cultured overnight in RPMI 1640 supplemented with 1% FBS and subsequently stimulated with Flt3 ligand (100 ng/ml) (a friendly gift from Immunex Corporation, Seattle, WA, USA). Nuclear extracts were prepared according to the miniscale procedure described. 24 Nuclear extracts were divided into small aliquots and stored at À801C. Cytoplasmic extracts were normalized for protein content and analyzed for the amount of phosphorylated IkB by Western blotting. Double-stranded synthetic oligonucleotide probes containing the NF-kB (NF-kB: 5 0 -AGCTGCGGGGATTTTCCCTG-3') consensus sequence (underlined) were used in the gel retardation assay. A measure of 50 ng of HPLC-purified single-stranded oligonucleotide was labeled with T4-polynucleotide kinase and [a 32 p]dATP (3000 Ci/mmol, Amersham), separated from nonincorporated radiolabel by Sephad ex G50 chromatography, ethanol precipitated, dried, and dissolved in 20 ml of 10 mM TrisHCl (pH 7.5), 50 mM NaCl, 10 mM MgCl 2 , 1 mM EDTA and 1 mM DTT, containing a four-fold excess of the opposite strand. Annealing of the two complementary strands was performed by heating the mixture for 2 min at 901C and slow cooling to room temperature. The nuclear extract (5 mg) and 0.1 ng doublestranded labeled oligonucleotide were incubated in 20 mM HEPES (pH 7.9), 60 mM KCl, 0.06 mM EDTA, 0.6 mM DTT, 2 mM spermidine and 10% glycerol, supplemented with 2 mg poly(dI-dC). The binding reaction was performed at 261C for 25 min. The samples were loaded on prerun (30 min, 100 V) 4% (30:1) polyacrylamide gels, and run for 1 h at 150 V in 0.5 Â TBE at room temperature. Gels were dried and exposed to Kodak XAR films at À801C with an intensifying screen. Quantification of protein binding was performed by densitometry using a Phospho Imager (Molecular Dynamics, Sunnyvale, CA, USA). Cold competition (cc) experiments were performed by adding a 100-fold molar excess of unlabeled self-double-stranded oligonucleotides. Supershift experiments were performed by incubat-ing the nuclear extracts with polyclonal antibodies against p50 and p65 subunits of NF-kB (Santa Cruz).
Ras-binding reaction
AML cells (5 Â 10 6 ) and cell lines were incubated in 2 ml RPMI 1640 medium supplemented with 0.5% FBS for 24 h. Subsequently, cells were harvested and lysed in 400 ml lysis buffer (10% glycerol, 1% NP-40, 50 mM Tris/HCl pH 7.5, 200 mM NaCl, 2 mM MgCl 2 , 2 mg/ml aprotinin and protease inhibitors) for 10 min on ice. Cell lysates were clarified for 10 min at 41C by centrifugation at 10 000 g and incubated for 1 h with 10 mg of Raf-GDS glutathione-S-transferase-Ras-binding domain (GST-RBD) precoupled to glutathione-sepharose beads (Pharmacia). Subsequently, the beads were washed once with lysis buffer and 20 ml of SDS-sample buffer was added to the beads. The bound proteins were resolved on 15% SDS-PAGE gel and detected by immunoblotting using N-Ras antibody (Santa Cruz).
Bacterial expression and purification of the Raf-GDS GST-RBD fusion protein (a friendly gift from P Coffer, Utrecht, The Netherlands) has been described previously. 25 
Mutation analysis of N-and K-Ras
Mutation analysis of N-Ras was performed by single-strand conformation polymorphism (SSCP). Genomic DNA was extracted from AML cells as previously described. 26 PCR analysis was performed using primers
0 for amplification of a 149-bp exon 1 fragment containing codons 12 and 13. The primers 2FW 5 0 -CAAGTGGT-TATAGATGGTG-3 0 and 2BW 5 0 -ATAATGACTCCTAGTACCTG-3 0 were used to amplify a 181 bp exon 2 fragment containing codon 61. The PCR reaction was performed using 200 ng of genomic DNA in a total volume of 25 ml using 0.5 U of Taq polymerase (Gibco BRL, Grand Island, NY, USA) and 0.1 ml label ( 32 Pd-CTP), according to the manufacturer's recommendations. For SSCP analysis, 5 ml of PCR product was denatured for 2 min at 961C with an equal volume of stop solution (95% formamide, 10 mM NaOH, 0.25% bromophenol blue, 0.25% xylene cyanol), and then placed on ice. A volume of 5 ml sample was loaded onto a 0.5 Â MDE polyacrylamide gel (FMC Bioproducts) and electrophoresed at room temperature for 16 h at 250 V. After electrophoresis, a Kodak film was exposed to the gel for 16-24 h. Samples that demonstrated shifted singlestranded DNA fragments were amplified again without radiolabeling, and purified using a PCR purification kit (Qiagen Inc, Chatsworth, CA, USA). Subsequently, DNA fragments were sequenced in both directions using an ABI 377 automated sequencer.
Mutation analysis of the complete coding region of the K-Ras gene was performed according to a protocol using denaturing gradient gel electrophoresis (DGGE) analysis, as described before. 27 Immunoprecipitation AML blasts (2 Â 10 7 ) were cultured for 24 h in RPMI 1640 medium supplemented with 10% FBS. Cells were harvested, washed with ice-cold PBS containing 1 mM sodium orthovanadate and subsequently lysed in 500 ml lysis buffer (50 mM HEPES, pH 7.4, 10% glycerol, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 25 mM NaF, proteinase inhibitors (Complete: Boehringer Mannheim, Germany), 1 mM pepstatin, 1 mM sodium orthovanadate) for 10 min on ice. Cell lysates were clarified at 20 000 g for 20 min and then precleared with 30 ml protein A-sepharose beads (50% slurry) for 1 h at 41C. After 5 min centrifugation at 380 r.p.m., the cell lysates were incubated with 5 ml Flt3 antibody (C-20: Santa Cruz, CA, USA) rotating overnight at 41C. Protein A-sepharose beads (30 ml) were added to each sample and incubated for another 4 h at 41C. The immune complex was washed three times with lysis buffer. 1/10th of the precipitate was analyzed for the amount of precipitated Flt3 protein and 9/10th was analyzed for the degree of tyrosine-phosphorylated Flt3. The immune complexes were heated in sample buffer, separated by SDS-PAGE, immunoblotted on PVDF membrane (Millipore, Bedford, MA, USA) and incubated overnight with either antiphosphotyrosine (4G10, Upstate Biotechnology, Lake Placid, NY, USA) or anti-Flt3 antibody. Immunocomplexes were detected using ECL (Amersham, UK).
Analysis of the internal tandem duplication of the Flt3 gene
Genomic DNA was extracted from AML cells and Flt3 gene duplications were identified by allele-specific PCR amplification, followed by PAGE analysis. 26 Therefore, PCR amplification was performed by using the forward primer for exon 11: 5 0 -GCAATTTAGGTATGAAAGCCAGC-3 0 , and the reverse primer for exon 12: 5 0 -CTTTCAGCATTTTGACGGCAACC-3 0 , comprising the complete exon 11-12 region of the Flt3 gene, which contains internal tandem duplications, as described by previous studies. 26, 28, 29 The PCR was performed using 200 ng of genomic DNA in a total volume of 50 ml using 1 U of Taq polymerase (Gibco BRL, Grand Island, NY, USA), according to the manufacturer's recommendations.
The amplified PCR product was run on a 7.5% acryl/bisacrylamide gel (29:1) cut out from the gel and dissolved in 40 ml H 2 O overnight at 41C. A volume of 20 ml of this dissolved PCR product was used for another PCR reaction under the same conditions as described above. The amplified PCR product was purified with a PCR purification kit (Qiagen Inc, Chatsworth, CA, USA) and directly sequenced using the forward primer for exon 11.
Statistical analysis
The Student's t-test was used to determine the significance of the apoptosis data in conjuction with NF-kB-positive and -negative samples. To determine if levels of phosphorylated PKB after L-744832 and Ly294002 treatment differed from control cells, densitometric analysis was followed by the Student's t-test. To demonstrate a correlation between the expression patterns of different proteins, the Spearman's rank correlation coefficient was determined.
Results
Constitutive NF-kB DNA-binding activity in AML blasts
Blasts of 22 patients with AML (FAB classifications:
) and two cell lines (TF-1, THP-1) were studied with regard to their constitutive NF-kB DNA-binding activity, by means of EMSA. The specificity of the NF-kB DNA binding was shown by competition assay by adding a 100-fold molar excess of unlabeled oligonucleotide (Figure 1b) . In addition, no difference was observed for NF-kB expression in fresh AML samples vs that in cells studied after thawing and culturing. In 16 (73%) cases, constitutive NF-kB DNA-binding activity could be demonstrated, while six cases showed no or only minor levels of NF-kB DNA-binding activity (representative data are shown in Figure 1a and summarized in Table 1 ). Supershift experiments performed with four different AML cases with antibodies specific for the p50 and p65 subunits of the NF-kB family indicated that the NF-kB complexes consisted of these subunits (Figure 1b) . The constitutive NF-kB DNA-binding activity could not be correlated with distinct AML FAB classifications.
Low spontaneous apoptosis of AML blasts correlated with constitutive NF-kB DNA-binding activity Since it has been described that NF-kB plays an important role in cell survival, 4 we examined whether, also for AML cells, constitutive NF-kB DNA-binding activity had an effect on the viability of the cells. AML cells were cultured for 24 h in 10% FBS and the percentage of apoptotic cells was determined by Annexin V/PI staining. As is shown in Table 1 , AML cases with distinct NF-kB activity (n ¼ 16) demonstrated a significant lower percentage of apoptotic cells (28713.9%) vs the six cases with no NF-kB activity (54.3714.9% Po0.001).
In order to confirm that NF-kB DNA binding effectively protects AML blasts against apoptosis, we used a specific NF-kB inhibitor, the SN-50 peptide, that protects nuclear import of NFkB. To this end, AML cells with high constitutive NF-kB DNAbinding activity were incubated with the SN-50 peptide and the percentage of apoptotic cells was determined. Addition of SN-50 (100 mg/ml) enhanced the VP-16 (50 mg/ml)-induced apoptosis by 1375% after 24 h of culture in five of seven cases. VP-16 is an etoposide that induces apoptosis due to inhibition of the resealing activity of topoisomerase II. 30 The inhibitory effect of SN-50 was specific since SN-50 inhibited the PMA-induced NFkB activity without an effect on the PMA-induced p21 expression (Figure 1c ).
Constitutive Ras activity in AML blasts
In order to elucidate the underlying mechanism responsible for NF-kB activation, we examined whether N-Ras might be constitutively activated in the AML cases. Constitutive N-Ras activity was examined by using the RBD of Raf fused to GST as an activation-specific probe. Western blotting using N-Ras antibodies was performed to detect the binding of GTP-Ras with GST-RBD. As demonstrated in Figure 2 and summarized in Table 1 , 15 AML cases demonstrated constitutive N-Ras activity. This constitutive Ras activity correlated with constitutive NF-kB DNA-binding activity (Po0.05). In addition, the expression level of the N-Ras protein was studied for the different AML cases, demonstrating that the amount of Ras protein varied strongly between the different AML cases. The specificity of the Ras pull-down assay was studied by activating AML cells with and without GM-CSF. Upon stimulation for 15 min, a strong increase in Ras-GTP was shown (Figure 2b) .
The most commonly observed mutations in N-Ras arise at sites critical for gene regulation, namely codons 12, 13 and 61. 16, 17 In order to identify the origin of constitutive Ras activity, we screened for mutations in codons 12, 13, or 61 of the N-Ras gene by PCR-SSCP analysis and DGGE analysis, to identify the possible mutations in the K-Ras gene. As shown in Table 1 Constitutive NF-kB DNA-binding activity in AML blasts. (a) AML cells were cultured for 24 h in RPMI 1640 medium with 10% FBS. Nuclear extracts were prepared according to the miniscale procedure, normalized for protein content and NF-kB DNA-binding activity was determined by EMSA, using double-stranded synthetic oligonucleotide probes containing the NF-kB (NF-kB: 5 0 -AGCTGCGGGGATTTTCCCTG-3') consensus sequence (underlined). (Representative data from 11 AML cases are shown.) (b) Supershift experiments were performed by incubating the nuclear extracts with polyclonal antibodies against p50 and p65 subunits of NF-kB. Slower migrating bands are indicative of the presence of that particular subunit in the complex and thus demonstrate the composition of the NF-kB complex. The specificity of the NF-kB DNA binding was performed with a cc assay, as described in materials and methods. (One representative case is shown.) (c) The NF-kB inhibitor SN-50 specifically inhibits NF-kB DNA-binding activity. Monocytes were stimulated with PMA after being preincubated with medium or SN-50. NF-kB activity was studied by EMSA and, in order to confirm specificity, total p21 expression was analyzed by Western blotting. Actin was used as loading control. Densitometric analysis (using the gelscan program Quantity One (Bio-Rad, Hercules, CA, USA)) revealed a three-fold inhibition of NF-kB DNA-binding activity after SN-50 treatment (data not shown).
Ras/PI3-K/PKB-dependent pathway mediates NF-jB binding KU Birkenkamp et al codon 12 (n ¼ 2), 13 (n ¼ 1) and 61 (n ¼ 2). Furthermore, no mutations were detected in the K-Ras gene. These data demonstrate that constitutive NF-kB DNA-binding activity coincided with constitutive Ras activity, but did not correlate with activating mutations in codons 12, 13 and 61 of the Ras gene.
Constitutive ERK phosphorylation
The classical downstream target of Ras is the Raf/MEK/ERK pathway. 18, 20 In addition, some studies have described that a lower percentage of apoptosis in the erythroleukemic TF-1 cell line is associated with higher ERK1/2 activity 31 and the ERK pathway has also been described to be involved in activating NF-kB DNA-binding activity.
14,32 Therefore, we investigated whether Ras activity coincided with constitutive ERK activity (Western blots not shown). As summarized in Table 1 , constitutive ERK activity was observed in 17 out of 22 AML cases. Although in 12 out of these 17 cases constitutive ERK activity corresponded with constitutive Ras activity, this correlation was demonstrated not be significant.
L-744832 and Ly294002 inhibit NF-kB DNA binding
In order to investigate the link between Ras and NF-kB in more detail and to elucidate the downstream effectors of Ras facilitating NF-kB activity, we examined the effect of chemical inhibitors, specific for different downstream targets of the Ras pathway, on constitutive NF-kB DNA-binding activity. AML blasts were cultured with or without addition of L-744832 (a farnesyl-transferase inhibitor, which blocks Ras activation), PD98059 (MEK1/2 inhibitor), Ly294002 (PI3-K inhibitor) and AG1296 (tyrosine kinase inhibitor). The concentrations used were able to block the respective kinases. In five of seven cases tested, the Ras inhibitor L-744832 and the PI3-K inhibitor Ly294002 were able to inhibit constitutive NF-kB DNA-binding activity, while AG1296 and PD98059 had no or limited effect. The results of four different cases are depicted in Figure 3 .
These data demonstrate that the ERK kinase, the classical downstream effector of Ras, is not involved in the constitutive NF-kB DNA-binding activity. In contrast, both L-744832 and Ly294002 inhibited constitutive NF-kB DNA-binding activity, suggesting that Ras might mediate NF-kB DNA-binding activity by a PI3-K-mediated pathway.
Constitutive PKB phosphorylation in AML
The classical downstream target of PI3-K is PKB/Akt, a protein which is known to prevent apoptosis. 33 Recently, several studies described the involvement of PKB in the activation of IKK, the upstream IkB kinase. 34, 35 Therefore, we examined whether PKB is constitutively activated in those AML cases that demonstrate constitutive NF-kB activity. In 14 of 22 investigated AML cases, constitutive PKB serine 473 phosphorylation correlated with constitutive NF-kB DNA-binding activity (Po0.05, Figure 4a , Table 1 ). Since activation of PKB not only involves phosphorylation at the serine 473 residue, but also phosphorylation at the threonine 308 residue, 36 nine AML samples with and without serine 473 phosphorylation were also investigated for threonine 308 phosphorylation. As shown in Figure 4b , almost all AML samples exhibited threonine 308 phosphorylation, thus leaving phosphorylation of serine 473 a good indicator of activated PKB. Although in 11 cases constitutive PKB activity coincided with 
FAB ¼ French-American-British classification, NF-kB ¼ analysis of NF-kB DNA-binding activity as determined by EMSA, described in Materials and methods; Ras activity is determined by the Ras-binding reaction described in Materials and methods; Ras mut. ¼ mutation of Ras, as determined by the analysis described in Materials and methods, (12), (13) both constitutive Ras activity and NF-kB DNA binding, no significant correlation could be found between Ras and PKB activity.
L-744832 and Ly294002 inhibit PKB phosphorylation in AML
In order to elucidate whether the constitutive activation of the PI3-K/PKB pathway in AML is due to constitutive Ras activation, we examined the effect of the Ras inhibitor L-744832 on spontaneous PKB phosphorylation of four AML cases with high constitutive Ras, PKB and NF-kB activity. As demonstrated in Figure 5a , addition of L-744832 strongly inhibited the spontaneous PKB phosphorylation, both on serine 473 and the threonine 308 residue. Similarly, addition of Ly294002 strongly reduced PKB phosphorylation on both residues. Western blots for total and phospho-Thr202/Tyr204 ERK1/2 are shown as evidence that the L-744832 compound is effective in inhibiting Ras. Densitometric analysis showed that this treatment with L-744832 and Ly294002 significantly reduced the levels of serineand threonine-phosphorylated PKB (n, nn, nnn and nnnn Po0.0001, Figure 5b ). The inhibition of Ras and PKB was also reflected at the level of NF-kB DNA binding (Figure 3 ). Both inhibition of Ras by L-744832 or PKB by Ly294002 resulted in a strong reduction of NF-kB DNA-binding activity. Constitutive Ras activity in AML blasts. (a) AML blasts were cultured for 24 h in RPMI 1640 medium with 0.5% FBS. Cell lysates were normalized for protein content and, subsequently, GTPbound Ras was precipitated from equal amounts of cell lysates using the RBD of Raf-GDS fused to GST as an activation specific probe. The bound proteins were analyzed by SDS-PAGE gel and detected by immunoblotting using N-Ras antibody (upper lane). As control for an estimate of the amount of protein used in the pull-down assay, equal amounts of total cell lysates before precipitation were western blotted and immunodetection was performed using antibodies against N-Ras (Ras input, middle lane) and actin (bottom lane). (Representative data from 15 cases are shown.) (b) The specificity of the Ras pull-down assay was studied by activating AML cells with and without GM-CSF ( þ and -control, respectively) for 15 min. Ras-GTP activity was determined as described in (a).
Figure 3
L-744832 and Ly294002 inhibit NF-kB DNA-binding activity. AML cells were cultured for 24 h in RPMI 1640 medium with 10% FBS supplemented with or without L-744832 (50 mM, Ras inhibitor), Ly294002 (5 mM, PI3-K inhibitor), AG1296 (20 mM, tyrosine kinase inhibitor) or PD98059 (10 mM, MEK1/2 inhibitor). Nuclear extracts were prepared, normalized for protein content and NF-kB DNA-binding activity was determined by EMSA. Four representative cases are shown.
Figure 4
Constitutive PKB phosphorylation in AML. (a) AML cells were cultured for 24 h in RPMI 1640 medium with 10% FBS. Total cell extracts were prepared and equal amounts of cell lysates were subjected to SDS-PAGE. Western blot analysis was performed using an antibody against phospho-PKB (Ser473). As a control, equal amounts of total cell lysates were Western blotted and immunodetection was performed using antibodies against total ERK1/2. (Representative data from 15 cases are shown.) (b) Cell lysates of AML cases with and without PKB Ser473 phosphorylation were Western blotted and subjected to immunodetection using antibodies against phospho-PKB (Thr308). Total PKB (PKB tot) and actin immunodetection were performed for loading control. Nine representative cases are shown.
Constitutive NF-kB activity is not caused by autocrine growth factor production To study whether autocrine growth factor production by AML blasts was responsible for NF-kB activation, a subset of AML blasts with high constitutive NF-kB and Ras activity (nos. 2, 6, 10, 5) were cultured for 24 h in 10% FBS and cell-free supernatant was collected. Subsequently, TF-1 cells, which are highly responsive for IL-1, IL-6, TNFa and GM-CSF, were stimulated for 10 min with conditioned AML medium (66%) and the effect on IkB phosphorylation and NF-kB DNA-binding activity was examined. As a positive control (to show that IL-1 can actually activate NF-kB in these cells), TF-1 cells were stimulated for 10 min with 10 ng/ml IL-1b. In addition, TNFa also strongly induced NF-kB DNA-binding activity in TF-1 cells (data not shown). As shown in Figure 6a , none of the AML supernatants induced IkB phosphorylation or distinct NF-kB DNA-binding activity, while incubation with IL-1 strongly induced both.
To exclude the possibility that the assay was not sensitive enough, the effect of neutralizing antibodies against IL-1, IL-6, GM-CSF and TNFa on the constitutive NF-kB DNA-binding activity of four different AML cases was examined. Although the antibodies were capable of inhibiting the cytokine-induced Erk phosphorylation (data not shown), after 24 h of cell culture no Total cell extracts were prepared and equal amounts of cell lysates were subjected to SDS-PAGE. Western blot analysis was performed using an antibody against phospho-PKB (Ser473), phospho-PKB (Thr308) and total PKB (PKB tot). In order to show that the L-744832 compound is an effective Ras inhibitor, immunodetection was performed against one of the downstream effectors of Ras, Phospho Erk1/2 (Thr202/Tyr204). As a control, equal amounts of total cell lysates were subjected to immunodetection using antibodies against ERK1/2 and actin. The data presented are representative of four individual cases. (b) Densitometric analysis was performed on the Western blots of P-Ser473 PKB and P-Thr308 PKB using the gelscan program Quantity One (Bio-Rad, Hercules, CA, USA) and normalized against total PKB. Untreated samples were set to 100%. A significant reduction of phosphorylated Ser473 PKB and phosphorylated Thr308 PKB were observed after treatment with the L-744832 and Ly294002 compounds (n, nn, nnn and nnnn Po0.0001). The data presented are averaged from three independent experiments, with error bars denoting standard deviations.
Figure 6
Constitutive NF-kB DNA-binding activity is not due to autocrine growth factor production. (a) In order to investigate whether an autocrine-produced growth factor is responsible for NF-kB DNAbinding activity, TF-1 cells were cultured in 1% FBS overnight and subsequently stimulated for 10 min with the conditioned medium of the indicated AML cases or IL-1b (10 ng/ml), as described in Results. Nuclear extracts were prepared, normalized for the amount of protein and NF-kB DNA-binding activity was determined by EMSA (upper panel). Total cell extracts were prepared and equal amounts of cell lysates were subjected to SDS-PAGE. Western blot analysis was performed using an antibody against phospho Ser32-IkB-a and total IkB-a (middle and lower panel). (b) AML blasts were cultured for 24 h in RPMI 1640 medium with 10% FBS supplemented with or without neutralizing antibodies against IL-1b, IL-6, GM-CSF or TNFa, to exclude the possibility that the assay was not sensitive enough. Nuclear extracts were prepared, normalized for protein content and NF-kB-binding activity was determined by EMSA (two representative examples are shown).
significant effect was observed on NF-kB DNA-binding activity by any of these neutralizing antibodies (two representative examples are shown in Figure 6b ).
Constitutive NF-kB DNA-binding activity is not due to Flt3 activity
Recently, several reports demonstrated a significant role for the Flt3 tyrosine kinase receptor in the resistance of AML blasts against apoptosis. 26, 28 In addition, internal tandem duplication (ITD) mutations in this receptor result in constitutive activation of the receptor and the subsequent activation of several downstream signal transduction cascades, for example, STAT5 and ERK pathway. 29 Therefore, we investigated whether constitutive NF-kB activity might be due to activation of the Flt3 receptor. First, we examined whether activation of the Flt3 receptor by its ligand could activate NF-kB DNA-binding activity. Stimulation of THP-1 cells with Flt3 ligand induced a distinct increase in NF-kB DNA-binding activity (Figure 7a ). In our subset of AML cases, 10 of 22 investigated AML cases demonstrated an ITD in the Flt3 gene (see Table 1 ). Of the 10 cases with an ITD, eight cases demonstrated constitutive activation of the receptor, while four cases demonstrated constitutive Flt3 activation without a mutation (Table 1) . It appeared that in nine of 12 cases constitutive Flt3 phosphorylation coincided with constitutive NF-kB DNA-binding activity. However, addition of the Flt3 inhibitor AG1296 had no effect on the constitutive NF-kB DNA-binding activity of the investigated AML blasts (two representative samples are shown in Figure 7b ), but significantly inhibited the Flt3-mediated STAT5 A/B tyrosine 694/699 phosphorylation, as depicted in Figure 7b .
In conclusion, Flt3 receptor activation does not account for constitutive NF-kB activity.
Discussion
Several lines of evidence suggest that NF-kB family members are involved in tumor growth. 4 Hodgkin's lymphoma cell lines contain constitutively active NF-kB, and inhibition of NF-kB by overexpression of a nondegradable IkBa molecule inhibits proliferation and tumorigenesis of these cells. 37 In addition, activation of NF-kB by tumor necrosis factor, ionizing radiation and chemotherapeutic agents was found to protect tumor cells from cell killing. 38, 39 Conversely, inhibition of this transcription factor enhanced apoptotic killing by these reagents, demonstrating that persistent activation of NF-kB represents a unique mechanism by which cells express genes that can protect against apoptotic stimuli.
In the present study, we demonstrate that, of the investigated AML cases, NF-kB was frequently constitutively activated. This constitutive NF-kB activity was associated with a lower percentage of spontaneous apoptosis, compared to AML cases that had no or low nuclear NF-kB expression. In addition, the expression is in general associated with a reduced sensitivity for chemotherapy-induced apoptosis.
Selective targeting of leukemic cells through inhibition of NFkB might be an effective way to enhance the therapeutic effect of existing AML treatment modalities. However, the most rational approach to inhibit NF-kB activity may require the identification of upstream activators. The Ras protein has been shown to be frequently mutated in AML, resulting in the constitutive activity of this GTP-ase, 16, 17 and is linked with cellular transformation. Here, we demonstrate that Ras activation was significantly correlated with the NF-kB DNA-binding activity in AML blasts. In 68% of the investigated AML cases, constitutive N-Ras activity was observed, which was associated with mutations in the N-Ras gene in 27% of the cases. The difference in Ras-GTP activity and the frequency of Ras mutations indicate that alternative causes are also of relevance. Recently, a mutation was identified in a Ras-guanine exchange factor in an AML case. 40 Whether these mutations or unidentified growth factors are responsible for the Ras activity will require further studies.
The finding that Ras activation is much more frequent than Ras-mutation is of interest, and suggests that the in vivo application of Ras inhibitors should not be restricted to patients with a mutated Ras gene, but that an effect can also be expected in a much larger group of patients.
The classical downstream target of Ras is the Raf/MEK/ERK pathway. 18, 20 Several studies described the involvement of the ERK pathway in activating NF-kB DNA binding and transactivation. 14, 32 In addition, inhibition of the MAPK pathway by several MEK inhibitors resulted in impaired cell growth and survival of AML cell lines and primary AML samples with constitutive MAPK activation. 41 However, although ERK was frequently constitutively activated in the AML cases, we did not find any effect of the MEK inhibitor PD98059 on NF-kB DNA-binding activity, which does not exclude the possibility that Erk might effect the NF-kB transactivation potential. 14 In contrast, we demonstrate that Ras mostly mediates NF-kB activation by a PI3-K/PKB-dependent pathway. In a number of the cases with constitutive NF-kB DNA-binding activity, both Ras and PKB were constitutively activated. The link between Ras and the PI3-K/PKB pathway was further confirmed by the fact that the farnesyl-transferase inhibitor L-744832 strongly inhibited PKB phosphorylation. In addition, L-744832 and Ly294002 both strongly inhibited NF-kB DNA-binding activity. These data implicate that a Ras/PI3-K/PKB-mediated pathway can mediate constitutive NF-kB DNA-binding activity. In addition, it Constitutive NF-kB DNA-binding activity is not due to Flt3 activity. (a) THP-1 cells were cultured overnight in 1% FBS, and subsequently stimulated with Flt3 ligand for the indicated periods of time, in order to test whether activation of the Flt3 receptor by its ligand could induce NF-kB DNA-binding activity. Nuclear extracts were prepared, normalized for protein content and NF-kB-binding activity was determined by EMSA. (b) AML blasts were cultured for 24 h in RPMI 1640 medium with 10% FBS supplemented with or without AG1296 (20 mM, Flt3 inhibitor). Nuclear extracts were prepared, normalized for protein content and NF-kB-binding activity was determined by EMSA. Although the used concentration of AG1296 (20 mM) did not inhibit NF-kB DNA-binding activity, it was effective since it inhibited the Flt3 (FL)-mediated STAT5A/B Tyr694/ 699 phosphorylation. As loading control, total STAT5 A/B is shown.
appeared that the constitutive NF-kB DNA-binding activity was unlikely caused by the production of autocrine growth factors. 42 Furthermore, although aberrant IKK signaling in AML has been described to lead to increased NF-kB activity, 12 this could not be detected in the present study, since AML supernatants did not induce IkB phosphorylation. Also, the frequently mutated and constitutively activated Flt3 receptor tyrosine kinase was not responsible for NF-kB activation. Therefore, an alternative mechanism, upstream of Ras, is responsible for the constitutive NF-kB activity. We speculate that a yet unknown GTP exchange factor, upstream kinase, or receptor is mutated, resulting in constitutive activation of this signal transduction pathway.
Our results and other findings indicate that a number of different signaling routes are triggered in AML cells with distinct and overlapping activities, including the STAT3 and STAT5 pathways, 26, 43 p21 expression in monocytic blasts [44] [45] [46] [47] and the RAS/PI3K/NF-kB pathway in these experiments, as well as by other investigations. 5, 28, 37, 48 In some cases, activation of these pathways might be triggered by the autocrine production of growth factors and hence might lead to enhanced survival and proliferation of the AML blast. 26, 43, 44, 49, 50 These findings are in line with the 'two-hit' model whereby two or more triggers are required for cellular transformation. The data also implicate that only a limited success will be obtained if a single inhibitor that targets only a small selection of genes is used.
In summary, our study demonstrates that two crucial antiapoptotic signaling molecules, Ras and PKB, interfere with the NF-kB pathway and result in constitutive activation of this transcription factor, which confers increased survival to AML blasts.
